121 related articles for article (PubMed ID: 709823)
1. Radioenzymatic assay of DOPA (3,4-dihydroxyphenylalanine).
Johnson GA; Gren JM; Kupiecki R
Clin Chem; 1978 Nov; 24(11):1927-30. PubMed ID: 709823
[TBL] [Abstract][Full Text] [Related]
2. A specific radioenzymatic assay for dihydroxyphenylalanine (DOPA). Plasma dopa may be the precursor of urine free dopamine.
Brown MJ; Dollery CT
Br J Clin Pharmacol; 1981 Jan; 11(1):79-83. PubMed ID: 6783056
[TBL] [Abstract][Full Text] [Related]
3. A sensitive radioenzymatic assay for dopamine, norepinephrine, and epinephrine in plasma and tissue.
Ben-Jonathan N; Porter JC
Endocrinology; 1976 Jun; 98(6):1497-507. PubMed ID: 1278114
[TBL] [Abstract][Full Text] [Related]
4. A simple radioenzymatic method to measure picogram amounts of DOPA in brain and biological fluids.
Argiolas A; Gessa GL
J Neurochem; 1981 Jan; 36(1):290-2. PubMed ID: 6780660
[TBL] [Abstract][Full Text] [Related]
5. Conjoint radioenzymatic measurement of catecholamines, their catechol metabolites and DOPA in biological samples.
Thiede HM; Kehr W
Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(1):19-28. PubMed ID: 6799844
[TBL] [Abstract][Full Text] [Related]
6. Effect of in vitro hemolysis on assay of plasma catecholamines and DOPA.
Smith RT
Clin Chem; 1980 Aug; 26(9):1354-6. PubMed ID: 6772343
[TBL] [Abstract][Full Text] [Related]
7. Plasma catecholamines in the chronically cannulated sheep fetus: predominance of L-dihydroxyphenylalanine.
Ben-Jonathan N; Arbogast LA; Rhoades TA; Schillo KK; Pau KY; Jackson GL
Endocrinology; 1983 Jul; 113(1):216-21. PubMed ID: 6407822
[TBL] [Abstract][Full Text] [Related]
8. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
Parada A; Loureiro AI; Vieira-Coelho MA; Hainzl D; Soares-da-Silva P
Eur J Pharmacol; 2001 May; 420(1):27-32. PubMed ID: 11412836
[TBL] [Abstract][Full Text] [Related]
9. Radioenzymatic assay of femtomole concentrations of DOPA in tissues and body fluids.
Zürcher G; Da Prada M
J Neurochem; 1979 Sep; 33(3):631-9. PubMed ID: 479880
[No Abstract] [Full Text] [Related]
10. Substrate stereospecificity and selectivity of catechol-O-methyltransferase for DOPA, DOPA derivatives and alpha-substituted catecholamines.
Gordonsmith RH; Raxworthy MJ; Gulliver PA
Biochem Pharmacol; 1982 Feb; 31(3):433-7. PubMed ID: 6803810
[TBL] [Abstract][Full Text] [Related]
11. Compartmental analysis of dopa decarboxylation in living brain from dynamic positron emission tomograms.
Cumming P; Gjedde A
Synapse; 1998 May; 29(1):37-61. PubMed ID: 9552174
[TBL] [Abstract][Full Text] [Related]
12. 3,4-dihydroxyphenylalanine (DOPA) decarboxylase deficiency and resultant high levels of plasma DOPA and dopamine in unfavorable neuroblastoma.
Ikeda H; Matsuyama S; Suzuki N; Takahashi A; Kuroiwa M
Hypertens Res; 1995 Jun; 18 Suppl 1():S209-10. PubMed ID: 8529065
[TBL] [Abstract][Full Text] [Related]
13. Derivation of urinary dopamine from plasma dopa.
Zimlichman R; Levinson PD; Kelly G; Stull R; Keiser HR; Goldstein DS
Clin Sci (Lond); 1988 Nov; 75(5):515-20. PubMed ID: 3151165
[TBL] [Abstract][Full Text] [Related]
14. Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable.
Shigetomi S; Kuchel O
Am J Hypertens; 1993 Jan; 6(1):33-40. PubMed ID: 8427659
[TBL] [Abstract][Full Text] [Related]
15. Melanoma detection by enzyme-radioimmunoassay of L-dopa, dopamine, and 3-O-methyldopamine in urine.
Faraj BA; Lawson DH; Nixon DW; Murray DR; Camp VM; Ali FM; Black M; Stacciarini W; Tarcan Y
Clin Chem; 1981 Jan; 27(1):108-12. PubMed ID: 7004664
[TBL] [Abstract][Full Text] [Related]
16. Single isotope derivative (radioenzymatic) methods in the measurement of catecholamines.
Johnson GA; Kupiecki RM; Baker CA
Metabolism; 1980 Nov; 29(11 Suppl 1):1106-13. PubMed ID: 7001177
[No Abstract] [Full Text] [Related]
17. Simple gas chromatographic analysis of plasma dopa and dopamine.
Mizuno Y
Clin Chim Acta; 1977 Jan; 74(1):11-9. PubMed ID: 832410
[TBL] [Abstract][Full Text] [Related]
18. Increase in plasma 3,4-dihydroxyphenylalanine (DOPA) appearance rate after inhibition of DOPA decarboxylase in humans.
Eldrup E; Hetland ML; Christensen NJ
Eur J Clin Invest; 1994 Mar; 24(3):205-11. PubMed ID: 8033956
[TBL] [Abstract][Full Text] [Related]
19. Catechol concentrations in the hemolymph of the scallop, Placopecten magellanicus.
Pani AK; Croll RP
Gen Comp Endocrinol; 2000 Apr; 118(1):48-56. PubMed ID: 10753566
[TBL] [Abstract][Full Text] [Related]
20. Effect of chronic L-DOPA administration of catecholamine metabolism in the rat.
Lancaster J; Sawyer PR; Shepherd DM; Turnbull MJ
Br J Pharmacol; 1973 Apr; 47(4):838-42. PubMed ID: 4723802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
